A carregar...

Ribavirin monotherapy increases sustained response rate in relapsers of end treatment virologic responders

AIM: To assess the efficacy of ribavirin monotherapy in patients with biochemical relapse after combination therapy. METHODS: Twenty-four weeks of ribavirin monotherapy was given to biochemical relapsers of end treatment biochemical responders within 6 mo after combination therapy, including non-res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Yen, Cho-Li, Chang, Jia-Jang, Lee, Tsung-Shih, Liu, Ching-Jung, Chen, Li-Wei, Chang, Liang-Che
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305950/
https://ncbi.nlm.nih.gov/pubmed/15786546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i11.1663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!